Literature DB >> 24659546

The European initiative for quality management in lung cancer care.

Torsten G Blum1, Anna Rich, David Baldwin, Paul Beckett, Dirk De Ruysscher, Corinne Faivre-Finn, Mina Gaga, Fernando Gamarra, Bogdan Grigoriu, Niels C G Hansen, Richard Hubbard, Rudolf Maria Huber, Erik Jakobsen, Dragana Jovanovic, Assia Konsoulova, Jens Kollmeier, Gilbert Massard, John McPhelim, Anne-Pascale Meert, Robert Milroy, Marianne Paesmans, Mick Peake, Paul-Martin Putora, Arnaud Scherpereel, Nicolas Schönfeld, Helmut Sitter, Knut Skaug, Stephen Spiro, Trond-Eirik Strand, Samya Taright, Michael Thomas, Paul E van Schil, Johan F Vansteenkiste, Rainer Wiewrodt, Jean-Paul Sculier.   

Abstract

Lung cancer is the commonest cause of cancer-related death worldwide and poses a significant respiratory disease burden. Little is known about the provision of lung cancer care across Europe. The overall aim of the Task Force was to investigate current practice in lung cancer care across Europe. The Task Force undertook four projects: 1) a narrative literature search on quality management of lung cancer; 2) a survey of national and local infrastructure for lung cancer care in Europe; 3) a benchmarking project on the quality of (inter)national lung cancer guidelines in Europe; and 4) a feasibility study of prospective data collection in a pan-European setting. There is little peer-reviewed literature on quality management in lung cancer care. The survey revealed important differences in the infrastructure of lung cancer care in Europe. The European guidelines that were assessed displayed wide variation in content and scope, as well as methodological quality but at the same time there was relevant duplication. The feasibility study demonstrated that it is, in principle, feasible to collect prospective demographic and clinical data on patients with lung cancer. Legal obligations vary among countries. The European Initiative for Quality Management in Lung Cancer Care has provided the first comprehensive snapshot of lung cancer care in Europe.

Entities:  

Mesh:

Year:  2014        PMID: 24659546     DOI: 10.1183/09031936.00106913

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  9 in total

Review 1.  Treatment of limited disease small cell lung cancer: the multidisciplinary team.

Authors:  Markus Glatzer; Achim Rittmeyer; Joachim Müller; Isabelle Opitz; Alexandros Papachristofilou; Ioannis Psallidas; Martin Früh; Diana Born; Paul Martin Putora
Journal:  Eur Respir J       Date:  2017-08-24       Impact factor: 16.671

2.  Prevalence of Cardiovascular Disease in Patients With Potentially Curable Malignancies: A National Registry Dataset Analysis.

Authors:  Nicolò Matteo Luca Battisti; Catherine A Welch; Michael Sweeting; Mark de Belder; John Deanfield; Clive Weston; Michael D Peake; David Adlam; Alistair Ring
Journal:  JACC CardioOncol       Date:  2022-06-21

Review 3.  Thoracic oncology HERMES: European curriculum recommendations for training in thoracic oncology.

Authors:  Fernando Gamarra; Julie-Lyn Noël; Alessandro Brunelli; Anne-Marie C Dingemans; Enriqueta Felip; Mina Gaga; Bogdan Dragos Grigoriu; Georgia Hardavella; Rudolf M Huber; Samuel Janes; Gilbert Massard; Paul Martin Putora; Jean-Paul Sculier; Philipp A Schnabel; Sara Ramella; Dirk Van Raemdonck; Anne-Pascale Meert
Journal:  Breathe (Sheff)       Date:  2016-09

Review 4.  Implementation of lung cancer multidisciplinary teams: a review of evidence-practice gaps.

Authors:  Nicole M Rankin; Elizabeth A Fradgley; David J Barnes
Journal:  Transl Lung Cancer Res       Date:  2020-08

5.  Continuous professional development: elevating thoracic oncology education in Europe.

Authors:  Wouter H van Geffen; Torsten G Blum; Stefano Aliberti; Kevin G Blyth; Clementine Bostantzoglou; Amy Farr; Bogdan Grigoriu; Georgia Hardavella; Rudolf M Huber; Nick Maskell; Gilbert Massard; Najib M Rahman; Daiana Stolz; Jan van Meerbeeck
Journal:  Breathe (Sheff)       Date:  2019-12

Review 6.  Multidisciplinary care models for patients with lung cancer.

Authors:  Georgia Hardavella; Armin Frille; Christina Theochari; Elli Keramida; Elena Bellou; Andreas Fotineas; Irma Bracka; Loukia Pappa; Vaia Zagana; Maria Palamiotou; Panagiotis Demertzis; Ioannis Karampinis
Journal:  Breathe (Sheff)       Date:  2020-12

7.  Is England closing the international gap in cancer survival?

Authors:  Sarah Walters; Sara Benitez-Majano; Patrick Muller; Michel P Coleman; Claudia Allemani; John Butler; Mick Peake; Marianne Grønlie Guren; Bengt Glimelius; Stefan Bergström; Lars Påhlman; Bernard Rachet
Journal:  Br J Cancer       Date:  2015-08-04       Impact factor: 7.640

8.  Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries.

Authors:  Anna Rich; David Baldwin; Inmaculada Alfageme; Paul Beckett; Thierry Berghmans; Stephen Brincat; Otto Burghuber; Alexandru Corlateanu; Tanja Cufer; Ronald Damhuis; Edvardas Danila; Joanna Domagala-Kulawik; Stefano Elia; Mina Gaga; Tuncay Goksel; Bogdan Grigoriu; Gunnar Hillerdal; Rudolf Maria Huber; Erik Jakobsen; Steinn Jonsson; Dragana Jovanovic; Elena Kavcova; Assia Konsoulova; Tanel Laisaar; Riitta Makitaro; Bakir Mehic; Robert Milroy; Judit Moldvay; Ross Morgan; Milda Nanushi; Marianne Paesmans; Paul Martin Putora; Miroslav Samarzija; Arnaud Scherpereel; Marc Schlesser; Jean-Paul Sculier; Jana Skrickova; Renato Sotto-Mayor; Trond-Eirik Strand; Paul Van Schil; Torsten-Gerriet Blum
Journal:  BMC Cancer       Date:  2018-11-20       Impact factor: 4.430

9.  Silencing of LINC00461 enhances radiosensitivity of lung adenocarcinoma cells by down-regulating HOXA10 via microRNA-195.

Authors:  Jiqiu Hou; Yanjun Wang; Hongmei Zhang; Yuxin Hu; Xiuqin Xin; Xiaodan Li
Journal:  J Cell Mol Med       Date:  2020-01-22       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.